DocuSign (NASDAQ: DOCU) CEO discloses Rule 10b5-1 stock sales by plan
Rhea-AI Filing Summary
DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 16,151 | $69.35 | $1.12M |
| Sale | Common Stock | 9,799 | $69.98 | $686K |
| Sale | Common Stock | 300 | $70.83 | $21K |
Footnotes (1)
- The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. The shares were sold at prices ranging from $68.77 to $69.76. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $69.77 to $70.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $70.77 to $70.93. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
FAQ
What insider activity did DocuSign (DOCU) report for Allan C. Thygesen?
DocuSign reported that Allan C. Thygesen, its President and CEO, sold shares of DocuSign common stock in three open-market transactions on January 9, 2026, and filed a Form 4 to disclose these trades.
Is the DocuSign CEO’s stock sale linked to a Rule 10b5-1 trading plan?
Yes. A footnote explains that the transactions were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person, indicating the trades were pre-arranged under that plan.
What price ranges applied to the DocuSign CEO’s stock sales on January 9, 2026?
Footnotes state that shares were sold in ranges of $68.77 to $69.76, $69.77 to $70.71, and $70.77 to $70.93. Detailed breakdowns by price are available from the reporting person on request.
What is the role of Allan C. Thygesen at DocuSign (DOCU)?
Allan C. Thygesen is identified in the filing as both a Director and an Officer of DocuSign, serving as President and CEO.